# Travere Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:9cae48cc-51cd-487b-8940-6df538bc1781 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/travere-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 31 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-11T04:45:42.923137+00:00 | | Last reviewed | 2026-10-11T04:45:42.923137+00:00 | ## Identity - Legal name: Travere Therapeutics, Inc. - Display name: Travere Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-11T21:35:35.383192+00:00 | | Completeness | 0.409 | | Record Quality | 0.839 | | Directors | 14 | | Committees | 1 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Christopher Cline: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: Accrued Compensation (2) Committee (member). claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:6 - Eric Dube, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. Committees: Accrued Compensation (2) Committee (member). claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:7 - Jeffrey Meckler: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:8 - John A. Orwin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:9 - Jula Inrig, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: Accrued Compensation (2) Committee (member). claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:10 - Peter Heerma: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: Accrued Compensation (2) Committee (member). claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:11 - Ron Squarer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:12 - Roy Baynes: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:13 - Ruth Williams-Brinkley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:14 - Sandra Poole: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:15 - Suzanne Bruhn: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:16 - Timothy Coughlin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:17 - William E. Rote: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-06. Committees: Accrued Compensation (2) Committee (member). claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:18 - Gary Lyons: Chair of the Board of Directors. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:5 ## Committees - Accrued Compensation (2) Committee (compensation). Chair: NOT_PUBLISHED. Members: Christopher Cline (member, current); Eric Dube, Ph.D. (member, current); Jula Inrig, M.D. (member, current); Peter Heerma (member, current); William E. Rote (member, current). committee_id=alpha:committee:travere-therapeutics-inc:accrued-compensation-2-committee ## Executive leadership - Wenbin Jiang, Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:24 - Christopher Cline: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:19 - Elizabeth E. Reed: Chief Legal Officer, General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:20 - Eric Dube, Ph.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:21 - Jula Inrig, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:22 - Peter Heerma: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:23 - William E. Rote, Ph.D.: Chief Research Officer. Status: unknown. claim_id=alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:25 ## Governance events - DIRECTOR_APPOINTED: Christopher Cline seat on Travere Therapeutics, Inc., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:sitnzf1ocsynz - DIRECTOR_APPOINTED: Jula Inrig, M.D. seat on Travere Therapeutics, Inc., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:zfvt0u1gmh2h8 - DIRECTOR_APPOINTED: Peter Heerma seat on Travere Therapeutics, Inc., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:1wsnobt1gybv55 - DIRECTOR_APPOINTED: William E. Rote seat on Travere Therapeutics, Inc., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:111nc8i1n4dk2c - EXECUTIVE_APPOINTED: Wenbin Jiang, Ph.D. executive of Travere Therapeutics, Inc., effective 2026-04-06. Effective: 2026-04-06. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:16aujer7hzxed - DIRECTOR_APPOINTED: Ruth Williams-Brinkley seat on Travere Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:pe0gq11gyw3fl - DIRECTOR_APPOINTED: Suzanne Bruhn seat on Travere Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:vrj4361jvb3y2 - DIRECTOR_APPOINTED: Eric Dube, Ph.D. seat on Travere Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:1emcsl2l794mk - DIRECTOR_APPOINTED: Sandra Poole seat on Travere Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:4o83rxyer08f - DIRECTOR_APPOINTED: John A. Orwin seat on Travere Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:1ry23foj4px6w - DIRECTOR_APPOINTED: Ron Squarer seat on Travere Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:l0u91c1dr74py - DIRECTOR_APPOINTED: Roy Baynes seat on Travere Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:nht9su18tqbbe - DIRECTOR_APPOINTED: Timothy Coughlin seat on Travere Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:138iqy1qutdxh - DIRECTOR_APPOINTED: Jeffrey Meckler seat on Travere Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-11T04:45:42.923137+00:00. event_id=alpha:event:transition:voa2ticxmr0i ## Scoped resources - `alpha://company/travere-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record - `alpha://company/travere-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=identity - `alpha://company/travere-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/travere-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=board - `alpha://company/travere-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=committees - `alpha://company/travere-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=leadership - `alpha://company/travere-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=ownership - `alpha://company/travere-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=financials - `alpha://company/travere-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/travere-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=compensation - `alpha://company/travere-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=governance - `alpha://company/travere-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/travere-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=audit - `alpha://company/travere-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=legal - `alpha://company/travere-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=risk - `alpha://company/travere-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=cyber - `alpha://company/travere-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/travere-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=agents - `alpha://company/travere-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/travere-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=events - `alpha://company/travere-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=relationships - `alpha://company/travere-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=assessments - `alpha://company/travere-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Accrued Compensation (2) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:christopher-cline","name":"Christopher Cline"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Accrued Compensation (2) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:eric-dube-ph-d","name":"Eric Dube, Ph.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Accrued Compensation (2) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jula-inrig-m-d","name":"Jula Inrig, M.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Accrued Compensation (2) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:peter-heerma","name":"Peter Heerma"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Accrued Compensation (2) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:william-e-rote-tvtx","name":"William E. Rote"},"source_id":"governance_people_committees"}` ## Leadership - Gary Lyons: Chair of the Board of Directors. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Christopher Cline: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:6. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Eric Dube, Ph.D.: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Jeffrey Meckler: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:8. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - John A. Orwin: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Jula Inrig, M.D.: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:10. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Peter Heerma: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:11. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Ron Squarer: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Roy Baynes: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:13. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Ruth Williams-Brinkley: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Sandra Poole: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:15. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Suzanne Bruhn: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:16. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Timothy Coughlin: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:17. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - William E. Rote: Director. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:18. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10. - Christopher Cline: Chief Financial Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Elizabeth E. Reed: Chief Legal Officer, General Counsel and Corporate Secretary. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Eric Dube, Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Jula Inrig, M.D.: Chief Medical Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Peter Heerma: Chief Commercial Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. - Wenbin Jiang, Ph.D.: Named Executive Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:24. Valid from: 2026-04-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:267f958d81b6591044b699c37ce1f50633267e4ed9a381ee1f63fbccd9584837. - William E. Rote, Ph.D.: Chief Research Officer. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Accrued Compensation (2) Committee: Chair not stated; Members Christopher Cline; Eric Dube, Ph.D.; Jula Inrig, M.D.; Peter Heerma; William E. Rote. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Travere Therapeutics, Inc.. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a3cdd727ad2962cf2ce6a9419666a61671a8433b5b74d649d11658d31230fcc0. ## Entity Status - Public listing published. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a3cdd727ad2962cf2ce6a9419666a61671a8433b5b74d649d11658d31230fcc0. ## Published Fact - US. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a3cdd727ad2962cf2ce6a9419666a61671a8433b5b74d649d11658d31230fcc0. ## Committee Appointment - Christopher Cline: member, Accrued Compensation (2) Committee. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. - Eric Dube, Ph.D.: member, Accrued Compensation (2) Committee. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. - Jula Inrig, M.D.: member, Accrued Compensation (2) Committee. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. - Peter Heerma: member, Accrued Compensation (2) Committee. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. - William E. Rote: member, Accrued Compensation (2) Committee. Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444. ## Security Listing - TVTX (NASDAQ). Claim: alpha:claim:company:9cae48cc-51cd-487b-8940-6df538bc1781:security_listing:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a3cdd727ad2962cf2ce6a9419666a61671a8433b5b74d649d11658d31230fcc0. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a3cdd727ad2962cf2ce6a9419666a61671a8433b5b74d649d11658d31230fcc0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/travere-therapeutics-inc). - alpha:projection-evidence:document:3282143f800cb3dc7977e07974d67b5bcc229548e8630f7c65a011817212257f: [SEC DEF 14A 0001438533-26-000027](https://www.sec.gov/Archives/edgar/data/1438533/000143853326000027/tvtx-20260404.htm). - alpha:projection-evidence:document:95034d2dd898352fbae536f09a863778894cc86ce46416bd8e338780ce6a2d10: [DEF 14A tvtx-20260404.htm](https://www.sec.gov/Archives/edgar/data/1438533/000143853326000027/tvtx-20260404.htm). - alpha:projection-evidence:document:267f958d81b6591044b699c37ce1f50633267e4ed9a381ee1f63fbccd9584837: [TVTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1438533/000143853326000027/tvtx-20260404.htm). - alpha:projection-evidence:f7b34fc93f64fee653f54bbea67236794e771fbbe5567ceff1ee1278be2ad444: [Accrued Compensation (2) Committee](https://www.sec.gov/Archives/edgar/data/1438533/000143853326000027/tvtx-20260404.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/travere-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/travere-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/travere-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/travere-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-11T21:35:35.18568+00:00; recorded 2026-10-11T21:35:35.18568+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.